Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jan 09, 2024 | Jan 12, 2024 | Krause Kevin Michael Chief Strategy Officer | Sell | An2 Therapeutics, Inc. | ANTX | $20.14 | $149,367 | -79.49% |
Jan 02, 2024 | Jan 04, 2024 | Krause Kevin Michael Chief Strategy Officer | Sell | An2 Therapeutics, Inc. | ANTX | $20.12 | $51,967 | -57.44% |